help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 72, No. 4 876-882
doi:10.1210/jcem-72-4-876
Copyright © 1991 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by CIARALDI, T. P.
Right arrow Articles by OLEFSKY, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by CIARALDI, T. P.
Right arrow Articles by OLEFSKY, J. M.

Insulin Action Kinetics in Adipocytes from Obese and Noninsulin-Dependent Diabetes Mellitus Subjects: Identification of Multiple Cellular Defects in Glucose Transport*

THEODORE P. CIARALDI, JOSEPH M. MOLINA and JERROLD M. OLEFSKY

Division of Endocrinology and Metabolism, Department of Medicine, University of California School of Medicine La Jolla, California 92093; and the Veterans Administration Medical Center, Medical Research Service San Diego, California 92161

Address all correspondence and requests for reprints to: Theodore P. Ciaraldi, Ph.D., Veterans Administration Medical Center, Medical Research Service (V-111G), 3350 La Jolla Village Drive, San Diego, California 92161.

Recent results from in vivo studies have shown that the kinetics of insulin action are impaired in lean and obese noninsulin-dependent diabetes mellitus (NIDDM) subjects as well as in obese nondiabetic subjects. We have measured the onset and loss of insulin action on glucose transport in adipocytes obtained from obese nondiabetic and obese NIDDM subjects to determine the contributions of obesity and diabetes to these cellular defects in insulin action. Basal and maximally insulin-stimulated rates of 3-O-methylglucose transport in adipocytes from obese and obese NIDDM subjects were reduced to 50% of the values in cells from normal subjects (P < 0.05). The activation of glucose transport by insulin (4.3 nmol/L) was slower in cells from obese NIDDM patients. Half of the maximal insulin effect (A50) was reached by 23.0 ± 5.0 min compared to 9.4 ± 1.1 min in normal cells (P < 0.05). Conversely, the deactivation of insulin-stimulated glucose transport upon removal of insulin was more rapid in adipocytes from the obese and obese NIDDM subjects. Half of the maximal insulin effect (D50) was lost by 12.4 ± 1.7 min in obese NIDDM cells and by 8.9 ± 1.9 min in obese subjects compared to 25.3 ± 1.9 min in adipocytes from normal subjects (P < 0.01). In conclusion, 1) basal and insulin-stimulated rates of glucose transport are similarly reduced in adipocytes from obese and obese NIDDM subjects; and 2) adipocytes from obese and obese NIDDM subjects display defects in the kinetics of insulin action, slower activation and accelerated deactivation, that mirror the defects measured in vivo. Both impairments in the kinetics of insulin action may contribute to the insulin resistance in these subject groups. (J Clin Endocrinol Metab 72: 876–882, 1991)

* This work was supported by funds from the Medical Research Service of the V.A., NIH Grants DK-33649 and DK-33651, NIH Training Grant DK-07494, V.A. Associate Investigators Award (to J.M.M.), and the V.A. Special Diagnostic and Treatment Unit.

Received August 14, 1990.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
J. P. Kirwan, A. Varastehpour, M. Jing, L. Presley, J. Shao, J. E. Friedman, and P. M. Catalano
Reversal of Insulin Resistance Postpartum Is Linked to Enhanced Skeletal Muscle Insulin Signaling
J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4678 - 4684.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. A. Virtanen, P. Lonnroth, R. Parkkola, P. Peltoniemi, M. Asola, T. Viljanen, T. Tolvanen, J. Knuuti, T. Ronnemaa, R. Huupponen, et al.
Glucose Uptake and Perfusion in Subcutaneous and Visceral Adipose Tissue during Insulin Stimulation in Nonobese and Obese Humans
J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3902 - 3910.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. P. Ciaraldi, A. J. Morales, M. G. Hickman, R. Odom-Ford, J. M. Olefsky, and S. S. C. Yen
Cellular Insulin Resistance in Adipocytes from Obese Polycystic Ovary Syndrome Subjects Involves Adenosine Modulation of Insulin Sensitivity
J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1421 - 1425.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1991 by The Endocrine Society